AzTrials
AzTrials

Primary Open Angle GlaucomaNCT05605743

Alternate Nostril Breathing Training in Geriatrics With Glaucoma and High Blood Pressure

A study testing breathing exercise in people with Primary Open Angle Glaucoma and Hypertension, run by Cairo University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Hypertension, particularly if poorly controlled, appears related to an increased risk of open angle glaucoma, (the high tension type of glaucoma is characterized as optic nerve degeneration with ocular hypertension). so this study will search response of glaucoma to breathing exercise Read more about this study

Who is it for?
Ages 65 to 75 years
Conditions the study is for
Primary Open Angle Glaucoma, Hypertension
What is being tested?
breathing exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteEgypt
Study dates
15 Sep 2022to 15 Jan 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 to 75 years
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • hypertensive elderly
  • primary open angle glaucoma in both eyes
  • ocular hypertension in both eyes

Who cannot join

  • acute or chronic eye inflammation cataract eye surgeries mental ill patients patients who will refuse to participate in the study other systemic /cardiovascular problem

Trial locations and contacts

1 site in 1 country.

Ali Ismail, lecturer contact

02 01005154209

ali.mohamed@pt.cu.edu.eg

mona taha, professor contact

monaday2007@yahoo.com

Egypt1 site, 1 recruiting
  • Faculty of Physical Therapy Cairo University

    Giza, Dokki

    Ali Ismail, lecturer, 02 01005154209, allooka2012@gmail.com

    Recruiting

Other trials in Egypt

About this study

Official title: Ocular Hypertension Response to Alternate Nostril Breathing Training in Geriatrics With Glaucoma and High Blood Pressure

Hypertension, particularly if poorly controlled, appears related to an increased risk of open angle glaucoma, (the high tension type of glaucoma is characterized as optic nerve degeneration with ocular hypertension). so this study will search response of glaucoma to breathing exercise

Read the detailed description

Hypertension, particularly if poorly controlled, appears related to an increased risk of open angle glaucoma, (the high tension type of glaucoma is characterized as optic nerve degeneration with ocular hypertension). With a random assignment, sixty hypertensive geriatric with high tension type primary open angle glaucoma will be assigned to breathing exercise (alternate nostril breathing) group (n=30 geriatrics) or waiting list geriatrics. the daily breathing exercise will be performed by the geriatrics in evening (for half an hour) and morning (for half an hour).

Being tested
breathing exercise
Medical subject headings
Glaucoma, Open-Angle, Hypertension

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • breathing exerciseBehavioural

    Thirty hypertensive geriatric with high tension type primary open angle glaucoma will perform breathing exercise (alternate nostril breathing). The daily breathing exercise will be performed by the geriatrics in evening (for half an hour) and morning (for half an hour) for one month.

Study groups in NCT05605743
Study groupRoleWhat they receive
Exercised groupExperimentalThirty hypertensive geriatric with high tension type primary open angle glaucoma will perform breathing exercise (alternate nostril breathing). The daily breathing exercise will be performed by the geriatrics in evening (for half an hour) and morning (for half an hour) for one month.
Receives: Behavioral: breathing exercise
control groupNo interventionthis will be a thirty-patient wait-list group that will no receive any shape of training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. intraoccular pressure

    it will be measured in right and left eyes

    Measured: It will be measured after 4 weeks of training

Secondary outcomes (7)
  1. systolic blood pressure

    it will be measured sphygmomanometer

    Measured: It will be measured after 4 weeks of training

  2. diastolic blood pressure

    it will be measured sphygmomanometer

    Measured: It will be measured after 4 weeks of training

  3. heart rate

    it will be measured manually

    Measured: It will be measured after 4 weeks of training

  4. respiratory rate

    it will be measured manually

    Measured: It will be measured after 4 weeks of training

  5. hospital anxiety and depression scale

    it contains fourteen questions. it contains two sub-scales, one for anxiety and the other for depression

    Measured: It will be measured after 4 weeks of training

  6. short form 36 survey

    in general, it will assess life quality

    Measured: It will be measured after 4 weeks of training

  7. glaucoma quality of life-15 questionnaire

    it will assess glaucoma-related life quality

    Measured: It will be measured after 4 weeks of training

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Nov 2022
  2. Study start15 Sep 2022
  3. Primary completion15 Jan 2023 (estimated)
  4. Study completion15 Jan 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05605743
Sponsor's protocol ID
P.T.REC/012/004006
Status last verified
Oct 2022
First submitted
30 Oct 2022
Last updated
4 Nov 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing breathing exercise in people with Primary Open Angle Glaucoma and Hypertension, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 4 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ali Ismail, lecturer (02 01005154209, ali.mohamed@pt.cu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

intraoccular pressure (time frame: It will be measured after 4 weeks of training). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Nov 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in